Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. June 09, 2023
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 12.00 p.m. and concluded at 04.30 p.m 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2023 Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Rescheduled Of Board Meeting
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2023 ,inter alia, to consider and approve Board Meeting which was supposed to be held today has been rescheduled to Friday June 09, 2023, since the consolidation of books of Harishree Aromatics and Chemicals Pvt Ltd on account of Amalgamation could not be completed on time Lasa Supergenerics Ltd - 540702 - Update on board meeting
The Board Meeting to be held on 29/05/2023 has been revised to 07/06/2023 The Board Meeting to be held on 29/05/2023 has been revised to 07/06/2023 Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to SEBI Circular CIR/CFD/CMD1/27/2019 Dated 8th February, 2019, please find enclosed copy of the Annual Secretarial Compliance Report dated May 26, 2023 issued by Shivam Sharma and Associates, for the financial year 2022-23 Lasa Supergenerics Ltd - 540702 - Nil Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue
As per the SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, issued by SEBI and pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in use of proceeds raised through preferential issue. A statement of deviation is enclosed herewith as Annexure A Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Director of the Company is scheduled to be held on Monday, May 29, 2023 1. To consider, approve and take on records Audited financial results of the Company for the quarter and year ended March 31, 2023. 2. To discuss any other matter with the permission of the Chairperson. Lasa Supergenerics Ltd - 540702 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyLasa Supergenerics Ltd 2CIN NO.L24233MH2016PLC274202 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Mitti Jain Designation: Company Secretary and Compliance Officer EmailId: cs@lasalabs.com Name of the Chief Financial Officer: Ravishankar Kabra Designation: CFO EmailId: raviskabra.rsk@gmail.com Date: 26/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and year ended on March 31, 2023 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company. Lasa Supergenerics Ltd - 540702 - YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OF SEBI (LODR) REGULATIONS 2015.
Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Practicing Company Secretary for the year ended March 31, 2023. Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For Year Ended 31/03/2023
As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to both physical and electronic share transfer facility during the period April 01, 2022 to March 31, 2023 (both days inclusive) are maintained by our Registrar & Share Transfer Agent - Bigshare Services Pvt. Ltd. having permanent SEBI Registration Number INR000001385.